Abstract
Background. Arm pain is common, costly to health services and society. Physiotherapy referral is standard management, and while awaiting treatment, advice is often given to rest, but the evidence base is weak.
Objective. To assess the cost-effectiveness of advice to remain active (AA) vs advice to rest (AR); and immediate physiotherapy (IP) vs usual care (waiting-list) physiotherapy (UCP).
Methods. 26-week within-trial economic evaluation (538 participants aged ≥18 years randomised to usual care i.e. AA(n=178), AR(n=182) or IP(n=178)). Regression analysis estimated differences in mean costs and Quality Adjusted Life Years (QALYs). Incremental cost-effectiveness ratios (ICERs) and cost-effectiveness acceptability curves were generated. Primary analysis comprised the 193 patients with complete resource use (UK NHS perspective) and EQ-5D data. Sensitivity analysis investigated uncertainty.
Results. Baseline adjusted cost differences were £88[95%CI:-14,201]) AA vs AR; -£14[95%CI:-87,66]) IP vs UCP. Baseline adjusted QALY differences were 0.0095[95% CI:-0.0140,0.0344]) AA vs AR; 0.0143[95%CI:-0.0077,0.0354]) IP vs UCP. There was a 71 % and 89% probability that AA (vs AR) and IP (vs UCP) were the most cost-effective option using a threshold of £20,000 per additional QALY. The results were robust in the sensitivity analysis.
Conclusion. The difference in mean costs and mean QALYs between the competing strategies was small and not statistically significant. However, decision-makers may judge that IP was not shown to be any more effective than delayed treatment, and was no more costly than delayed physiotherapy. AA is preferable to one that encourages AR, as it is more effective and more likely to be cost-effective than AR.
Objective. To assess the cost-effectiveness of advice to remain active (AA) vs advice to rest (AR); and immediate physiotherapy (IP) vs usual care (waiting-list) physiotherapy (UCP).
Methods. 26-week within-trial economic evaluation (538 participants aged ≥18 years randomised to usual care i.e. AA(n=178), AR(n=182) or IP(n=178)). Regression analysis estimated differences in mean costs and Quality Adjusted Life Years (QALYs). Incremental cost-effectiveness ratios (ICERs) and cost-effectiveness acceptability curves were generated. Primary analysis comprised the 193 patients with complete resource use (UK NHS perspective) and EQ-5D data. Sensitivity analysis investigated uncertainty.
Results. Baseline adjusted cost differences were £88[95%CI:-14,201]) AA vs AR; -£14[95%CI:-87,66]) IP vs UCP. Baseline adjusted QALY differences were 0.0095[95% CI:-0.0140,0.0344]) AA vs AR; 0.0143[95%CI:-0.0077,0.0354]) IP vs UCP. There was a 71 % and 89% probability that AA (vs AR) and IP (vs UCP) were the most cost-effective option using a threshold of £20,000 per additional QALY. The results were robust in the sensitivity analysis.
Conclusion. The difference in mean costs and mean QALYs between the competing strategies was small and not statistically significant. However, decision-makers may judge that IP was not shown to be any more effective than delayed treatment, and was no more costly than delayed physiotherapy. AA is preferable to one that encourages AR, as it is more effective and more likely to be cost-effective than AR.
| Original language | English |
|---|---|
| Journal | Family Practice |
| DOIs | |
| Publication status | Published - 6 Jun 2018 |
